Over the past few years, GLP-1 medications for weight loss such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have surged in popularity, including among older adults
To maximize potential benefits, patients should maintain consistent supplementation while following recommended dosages
Explore our educational research guide covering CJC-1295 with DAC and Ipamorelin in laboratory research contexts, peptide signalling discussions, and matched research bundle interest areas
NAD+ supports cellular energy production and mitochondrial function during the repair cycle, which amplifies the tissue-rebuilding effects of BPC-157 and TB-500
How to Manage Constipation on GLP-1 Medications Constipation is a common side effect when taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), or tirzepatide (Mounjaro)